Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander D Borgsteede

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Pharmacoepidemiology and Drug Safety|May 29, 2019
Nature and frequency of dosing instructions on prescription labels in primary careSander D Borgsteede, Mette Heringa
Nederlands Tijdschrift Voor Geneeskunde|March 2, 2021
[Allergic reactions to COVID-19 vaccines]Tjerk H Geersing, Žana Tempels-Pavlica, Sander D Borgsteede
Allergy|June 15, 2021
Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccinesSander D Borgsteede, Tjerk H Geersing, Žana Tempels-Pavlica
Journal of the Academy of Consultation-Liaison Psychiatry|January 1, 2023
Safety of Antipsychotics and Dose Recommendations in Patients With Cirrhosis From a Pharmacological PerspectiveSander D Borgsteede, Herold J Metselaar, Midas B Mulder
Gastroenterology|October 8, 2016
Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced CirrhosisRianne A Weersink, Joost P H Drenth, Sander D Borgsteede
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|February 23, 2020
No Causal Relation Between Bupropion in Therapeutic Dose and Serotonin ToxicitySander D Borgsteede, Tom K Birkenhager, Rianne J Zaal, et al.
British Journal of Clinical Pharmacology|September 25, 2018
The impact of CYP2D6 mediated drug-drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetineMuh Akbar Bahar, Jasper Kamp, Sander D Borgsteede, et al.
British Journal of Clinical Pharmacology|November 23, 2019
Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patientsRianne A Weersink, Marianna Abadier, Anthonius de Boer, et al.
Pharmacy (Basel, Switzerland)|October 28, 2025
Pharmacy Staff Experiences and Needs During Second Dispense of Driving-Impairing Medicines: A Qualitative StudyKarin Benning, Liset van Dijk, Johan Han J De Gier, et al.
Hepatology Communications|September 10, 2019
Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is AvailableRianne A Weersink, Joost P H Drenth, Nicole G M Hunfeld, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Pharmacoepidemiology and Drug Safety|May 29, 2019
Nature and frequency of dosing instructions on prescription labels in primary careSander D Borgsteede, Mette Heringa
Nederlands Tijdschrift Voor Geneeskunde|March 2, 2021
[Allergic reactions to COVID-19 vaccines]Tjerk H Geersing, Žana Tempels-Pavlica, Sander D Borgsteede
Allergy|June 15, 2021
Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccinesSander D Borgsteede, Tjerk H Geersing, Žana Tempels-Pavlica
Journal of the Academy of Consultation-Liaison Psychiatry|January 1, 2023
Safety of Antipsychotics and Dose Recommendations in Patients With Cirrhosis From a Pharmacological PerspectiveSander D Borgsteede, Herold J Metselaar, Midas B Mulder
Gastroenterology|October 8, 2016
Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced CirrhosisRianne A Weersink, Joost P H Drenth, Sander D Borgsteede
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|February 23, 2020
No Causal Relation Between Bupropion in Therapeutic Dose and Serotonin ToxicitySander D Borgsteede, Tom K Birkenhager, Rianne J Zaal, et al.
British Journal of Clinical Pharmacology|September 25, 2018
The impact of CYP2D6 mediated drug-drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetineMuh Akbar Bahar, Jasper Kamp, Sander D Borgsteede, et al.
British Journal of Clinical Pharmacology|November 23, 2019
Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patientsRianne A Weersink, Marianna Abadier, Anthonius de Boer, et al.
Pharmacy (Basel, Switzerland)|October 28, 2025
Pharmacy Staff Experiences and Needs During Second Dispense of Driving-Impairing Medicines: A Qualitative StudyKarin Benning, Liset van Dijk, Johan Han J De Gier, et al.
Hepatology Communications|September 10, 2019
Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is AvailableRianne A Weersink, Joost P H Drenth, Nicole G M Hunfeld, et al.
Pageof 6